Cargando…
Is There Still a Place for Tocilizumab in Coronavirus Disease 2019?
In this article, we sought to summarize the available evidence of tocilizumab as a treatment for coronavirus disease 2019. Recent tocilizumab randomized trials have not shown clear evidence of efficacy, especially on mortality, in contrast to observational studies. These clinical trials focus on a h...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7890594/ https://www.ncbi.nlm.nih.gov/pubmed/33628858 http://dx.doi.org/10.1093/ofid/ofab013 |